Data shows the effect of high protein versus high carbohydrate breakfast intake on glucose levels.

A systematic review to investigate the impact of intrauterine exposure to metformin on neonatal growth vs. insulin

Kidney failure is an enormous concern for people with T2D and DKD. This analysis confirms canagliflozin can slow its progression and have an impact on patients regardless of their level of kidney function.

The first oral glucagon-like peptide receptor agonist recently gained FDA approval, but how does it compare to oral agents already on the market?

by Guest Writer Richard Purcell
More than 100 million U.S. adults are now living with diabetes or prediabetes, according to the Centers for Disease Control and Prevention.1 This epidemic requires new healthcare models to deliver optimal, patient-focused, guideline-directed care to improve outcomes and reduce costs. The establishment of a new multispecialty Managed Services Organization (MSO) in Arizona spotlights the numerous benefits, to patients and providers alike, of providing end-to-end healthcare services and disease management solutions for complex diabetes.

This study covers the implications of sleep and its effect on behavioral and physiological implications in teens with type 1 diabetes.

Did the FDA make a mistake by labeling SGLT2 inhibitors as a fracture risk?

In regards to pharmacotherapy, patients with type 1 diabetes end up solely relying on insulin therapy for their diabetes management: what if there is an add on option?

After almost 50 years, is the age of sulfonylureas coming to an end?

The results of a recent phase III study may offer children with diabetes a new route for better glycemic control.